Hormonal changes in PCOS

J Yang, C Chen�- Journal of Endocrinology, 2024 - joe.bioscientifica.com
Polycystic ovary syndrome (PCOS) is a common endocrinopathy occurring in reproductive-
age women. Hyperandrogenism, polycystic ovaries, chronic anovulation, and metabolic�…

Gonadotropins as pharmacological agents in assisted reproductive technology and polycystic ovary syndrome

R Singh, S Kaur, S Yadav, S Bhatia�- Trends in Endocrinology & Metabolism, 2023 - cell.com
Polycystic ovary syndrome (PCOS) is a complex endocrinopathy associated with
subfertility/infertility and pregnancy complications. Most PCOS women opt for assisted�…

[HTML][HTML] Lean mass and associated factors in women with PCOS with different phenotypes

TM Fighera, BR Dos Santos, PM Spritzer�- Plos one, 2023 - journals.plos.org
Although current evidence suggests increased risk of obesity, insulin resistance, and
metabolic alterations in patients with polycystic ovary syndrome (PCOS), especially of a�…

[HTML][HTML] The role of the thyroid in polycystic ovary syndrome

H Fan, Q Ren, Z Sheng, G Deng, L Li�- Frontiers in Endocrinology, 2023 - frontiersin.org
Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disease in
women of childbearing age and can cause metabolic disorder, infertility, and increased�…

[HTML][HTML] Polycystic Ovary Syndrome: pathophysiology and controversies in diagnosis

D Fahs, D Salloum, M Nasrallah, G Ghazeeri�- Diagnostics, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder that commonly
affects women in the reproductive age group. The disorder has features that propose a�…

[HTML][HTML] Polycystic ovary syndrome and its management: In view of oxidative stress

K Bhattacharya, R Dey, D Sen, N Paul…�- Biomolecular�…, 2024 - degruyter.com
In the past two decades, oxidative stress (OS) has drawn a lot of interest due to the
revelation that individuals with many persistent disorders including diabetes, polycystic�…

[HTML][HTML] The role of MicroRNA, long non-coding RNA and circular RNA in the pathogenesis of polycystic ovary syndrome: A literature review

JS Nasser, N Altahoo, S Almosawi, A Alhermi…�- International journal of�…, 2024 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disease in
females of reproductive age, affecting 4–20% of pre-menopausal women worldwide�…

[HTML][HTML] Therapeutic effects and molecular mechanism of chlorogenic acid on polycystic ovarian syndrome: role of HIF-1alpha

Z Zhang, C Shi, Z Wang�- Nutrients, 2023 - mdpi.com
Chlorogenic acid (CGA) is a powerful antioxidant polyphenol molecule found in many diets
and liquid beverages, playing a preventive and therapeutic role in various diseases caused�…

[HTML][HTML] Pathophysiological effects of contemporary lifestyle on evolutionary-conserved survival mechanisms in polycystic ovary syndrome

J Parker�- Life, 2023 - mdpi.com
Polycystic ovary syndrome (PCOS) is increasingly being characterized as an evolutionary
mismatch disorder that presents with a complex mixture of metabolic and endocrine�…

[HTML][HTML] Molecular role of non-exonic variants in CALPAIN 10 gene in polycystic ovarian syndrome in Saudi women

AA Alageel, AF Alshammary, I Ali Khan�- Frontiers in Endocrinology, 2023 - frontiersin.org
Introduction Non-diabetic women with polycystic ovarian syndrome (PCOS) often have
abnormal insulin regulation. Calpain 10 (CALP10) is a biomarker of type 2 diabetes mellitus�…